Article
SOX2 as a Novel Marker to Predict Neoplastic Progression in Barrett’s Esophagus
1 Sept 2015
Abstract excerpt
OBJECTIVES: The value of Barrett's esophagus (BE) surveillance based on the histological diagnosis of low-grade dysplasia (LGD) remains debated given the lack of adequate risk stratification. The aim of this study was to evaluate the predictive value (PV) of SOX2 expression for neoplastic progression in BE patients. METHODS: We conducted a case-control study within a prospective cohort of 720 BE patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
